Manager, Corporate Communications, Millennium: The Takeda Oncology Company
Lindsay Treadway’s deep experience and understanding of the areas of global drug development (in many therapeutic areas including oncology, mental health, COPD, chronic pain, cardiovascular, ADHD) and patient advocacy make her a valuable member of Millennium's corporate communications team. Her hands-on background, in conjunction with her interpersonal skills, innovative thinking and team orientation, make Treadway an important asset within Millennium's communications infrastructure.
Treadway manages the communications around one of Millennium's strategic development collaboration with Seattle Genetics, a company with which they are co-developing a cancer drug, Adcetris. In the past year Treadway has directed the news flow coming out of this partnership, and Seattle Genetics’ stock has more than doubled during that time.